Experimental immune cell therapy tested for advanced gynecological cancers
NCT ID NCT06191900
First seen Apr 29, 2026 · Last updated May 17, 2026 · Updated 4 times
Summary
This early study tested an experimental therapy called GT201, made from a patient's own immune cells (tumor-infiltrating lymphocytes), for advanced gynecological tumors like cervical cancer. Only 4 people took part, and the main goal was to check safety and side effects. The study was stopped early, so it's not clear if this approach works well.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADULT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Shanghai Tenth People's Hospital
Shanghai, Shanghai Municipality, 200000, China
Conditions
Explore the condition pages connected to this study.